Latest news with #CovidVaccine
Bloomberg
3 hours ago
- Health
- Bloomberg
Moderna Will Test New Covid Shot Against Placebo, RFK Jr. Says
By and Rachel Cohrs Zhang Save Moderna Inc. has agreed to do a placebo-controlled trial of its new Covid vaccine that was recently approved by US regulators, Health and Human Services Secretary Robert F. Kennedy Jr. said Tuesday. In a post on X, Kennedy said he wanted to 'address those of you who have anxieties' about the Food and Drug Administration 's limited approval of Moderna's vaccine, which was cleared for a narrower segment of the population than prior shots.
Wall Street Journal
a day ago
- Business
- Wall Street Journal
How Moderna Went From Pandemic Hero to Vaccine Victim
Moderna MRNA 1.84%increase; green up pointing triangle was once a darling of the first Trump administration, which went to great lengths to help the company develop its Covid-19 vaccine that protected millions of people from the virus. Now the biotech is caught in the crossfire of Trump 2.0 as vaccine-making comes under fire. In the latest setback for Moderna MRNA 1.84%increase; green up pointing triangle, the Food and Drug Administration on Friday approved its next-generation Covid shot for a narrower population of patients than the company intended. The approval grants use of the vaccine only in older adults and people aged 12 to 64 with health risks.
Bloomberg
a day ago
- Business
- Bloomberg
Stock Movers: Broadcom, Moderna, Disney
- Broadcom (AVGO) is up today ahead of earnings this week. Bloomberg Intelligence analysts are expecting the software giant to post slightly better results and guidance led by strength in AI. - Moderna (MRNA) share rose after the drugmaker won FDA approval for its second-generation Covid vaccine. The company's second-generation vaccine is cleared for all adults over 65 and anyone over 12 who has at least one risk factor for severe disease, Moderna said in a statement Saturday. Moderna's Covid shot had previously been approved for people 12 years of age and older regardless of their underlying health. Vaccine makers have been on high alert to challenges under Kennedy, a longtime critic of immunizations who leads the health agency that oversees the Food and Drug Administration. - Disney (DIS) shares are lower after it was reported that it would be laying off several hundred employees across its film and TV businesses, cuts that underscore the tough times in Hollywood are far from over. The staff reductions began Monday and are falling on employees in marketing, publicity, casting and development, along with corporate financial operations, according to the company. Hollywood has been in a cost-cutting mode for years, with production and employment in a downward spiral. Disney, based in Burbank, California, announced a retrenchment in February 2023, eliminating 7,000 jobs in a bid to cut expenses by $5.5 billion. The company later increased that target to $7.5 billion. Competitors have also laid off thousands of workers.
Bloomberg
a day ago
- Business
- Bloomberg
Stock Movers: Boeing, Moderna
On this episode of Stock Movers: - Boeing (BA) shares gain after BofA Global Research upgraded the planemaker to buy from neutral, with analyst Ronald Epstein writing that company's 'aircraft emerged as the favored trade tool for the Trump administration in recent trade deals.' - Moderna (MRNA) shares rise after the drugmaker won FDA approval for its second-generation Covid vaccine for all adults over 65 and anyone over 12 who has at least one risk factor for severe disease.
Bloomberg
4 days ago
- Business
- Bloomberg
Moderna Wins Narrower US Approval for New Covid Vaccine
Moderna Inc. gained US approval for a new Covid vaccine for a narrower group of people, in the latest sign that regulators are restricting access to immunizations under the leadership of Health and Human Services Secretary Robert F. Kennedy Jr. The company's second-generation vaccine is cleared for all adults over 65 and anyone over 12 who has at least one risk factor for severe disease, Moderna said in a statement Saturday. Moderna's Covid shot had previously been approved for people 12 years of age and older regardless of their underlying health.
